03.04.15
Esteemed surgeon Dr. Dendy Engelman, director of Dermatological Surgery at New York Medical College, has joined the Board at NuGene International.
Ali Kharazmi CEO of NuGene, said: ”Dr. Engelman exemplifies the quality of character, experience and leadership that we seek in our advisory board. Her humanitarian efforts, awards and history reflect her desire to help people while providing the best patient experience possible. As a dermatological surgeon, she experiences on a daily basis many of the challenges that we seek to address through our NuGene technology.”
Engelman is a board certified dermatologic surgeon and an associate at Manhattan Dermatology & Cosmetic Surgery.Engelman has extensive training and experience in cosmetic dermatology –including neurotoxins, injectable fillers, and chemical peels. Engelman is also a fellow of the American Academy of Dermatology, American Society of Dermatologic Surgery and American College of Mohs Surgery.
"The possibilities for NuGene are very exciting," said Dr. Engelman. "Their current product lines for skin and hair care are exemplary, and I am even more excited about the opportunities with their new BioPharma subsidiary. Combining the NuGene technology with complementary products should be extremely interesting, and I have the opportunity to see the developments first hand.”
Ali Kharazmi CEO of NuGene, said: ”Dr. Engelman exemplifies the quality of character, experience and leadership that we seek in our advisory board. Her humanitarian efforts, awards and history reflect her desire to help people while providing the best patient experience possible. As a dermatological surgeon, she experiences on a daily basis many of the challenges that we seek to address through our NuGene technology.”
Engelman is a board certified dermatologic surgeon and an associate at Manhattan Dermatology & Cosmetic Surgery.Engelman has extensive training and experience in cosmetic dermatology –including neurotoxins, injectable fillers, and chemical peels. Engelman is also a fellow of the American Academy of Dermatology, American Society of Dermatologic Surgery and American College of Mohs Surgery.
"The possibilities for NuGene are very exciting," said Dr. Engelman. "Their current product lines for skin and hair care are exemplary, and I am even more excited about the opportunities with their new BioPharma subsidiary. Combining the NuGene technology with complementary products should be extremely interesting, and I have the opportunity to see the developments first hand.”